DSV Healthcare wins tender to distribute Pfizer vaccines across South Africa
2021/04/26
DSV Healthcare has been awarded the tender from the National Department of Health (NDoH) to distribute the Pfizer/BioNTech Covid-19 mRNA vaccine to vaccination centres across South Africa. This award is shared with The Biovac Institute, a public private partnership.
DSV is pleased to be able to utilise its existing infrastructure and capability to serve the South African community alongside the National Department of Health.
DSV is the largest private distributor of cold chain products to the public and private sectors in South Africa and has the experience, infrastructure, and cold chain capabilities to support the national initiative to vaccinate communities around the country. This expertise is especially crucial when handling the Pfizer vaccine which needs to be stored, handled, and distributed at -70˚C.
“The extremely low temperatures at which the Pfizer vaccine needs to be handled are, of course, a challenge which supports the need for the appropriate cold chain capabilities and a well-developed certified distribution network”, says Anthony Diack:
“DSV has one of the largest GDP compliant cold rooms in the Southern hemisphere and has spent many years investing in South African infrastructure and developing these specialised handling skills for both 2-8 ˚C and -70 ˚C, so I am confident we can bring the vital doses to the communities safely and securely.”
It is expected that the first doses will arrive to the country in the first week of May, followed by sampling and upon issuance of the Stability Certification the distribution of the first doses will commence.
Media inquiries
Inquiries from the media should be referred to:
South Africa: Candice Liebenberg, DSV South Africa, General Manager Marketing, Communications and Sales Training, +27 78 120 6595.
DSV is pleased to be able to utilise its existing infrastructure and capability to serve the South African community alongside the National Department of Health.
“This is a crucial task for South Africa and DSV Healthcare is pleased to have been selected as a nationwide distributor of the Pfizer COVID-19 vaccines. We take our contribution for the greater good of our people extremely seriously and have the utmost respect for the task at hand.”
says Anthony Diack, Managing Director of DSV Healthcare.
Well-developed infrastructure and cold-chain capabilities
DSV is the largest private distributor of cold chain products to the public and private sectors in South Africa and has the experience, infrastructure, and cold chain capabilities to support the national initiative to vaccinate communities around the country. This expertise is especially crucial when handling the Pfizer vaccine which needs to be stored, handled, and distributed at -70˚C.
“The extremely low temperatures at which the Pfizer vaccine needs to be handled are, of course, a challenge which supports the need for the appropriate cold chain capabilities and a well-developed certified distribution network”, says Anthony Diack:
“DSV has one of the largest GDP compliant cold rooms in the Southern hemisphere and has spent many years investing in South African infrastructure and developing these specialised handling skills for both 2-8 ˚C and -70 ˚C, so I am confident we can bring the vital doses to the communities safely and securely.”
It is expected that the first doses will arrive to the country in the first week of May, followed by sampling and upon issuance of the Stability Certification the distribution of the first doses will commence.
Media inquiries
Inquiries from the media should be referred to:
South Africa: Candice Liebenberg, DSV South Africa, General Manager Marketing, Communications and Sales Training, +27 78 120 6595.
Any questions?
Our experts are ready to help. Get in touch and we'll find the solution you need.
